Latest Going Concern News

Vectus Biosystems reports a narrowed half-year loss as it advances clinical drug VB0004 and nears a key asset sale to XORTX Therapeutics.

Cettire Limited reported a 2.8% revenue decline to $382.8 million and a net loss of $1.05 million for the half-year ended 31 December 2025, impacted by softer US demand and rising costs. Despite these headwinds, the company maintains a strong cash position and is focused on profitable growth.

Qoria Limited reported a 25% revenue increase to nearly $69 million for H1 FY2026 but also a widening net loss of $24.5 million. The company announced a transformative merger with US-based Aura to create a global digital safety leader.

Swoop Holdings Limited has reported a net loss for the half-year ended 31 December 2025, with auditors highlighting material uncertainty over the company’s ability to continue as a going concern. The mobile services provider faces operational and financial challenges as it pursues growth in a competitive market.

Control Bionics Limited reported a sharp increase in losses for the half-year ending December 2025, coinciding with its acquisition of full control over Neuro Elite Athletics, LLC. The company faces ongoing financial challenges despite no dividends being declared.

Babylon Pump & Power reported a $7.16 million loss for H1 FY26, weighed down by acquisition-related expenses and an impairment charge, while its rental segment soared post-acquisitions.

Bhagwan Marine reports a sharp 67% drop in net profit for the half-year to December 2025, while announcing a transformative $130 million acquisition of Riverside Marine Holdings.

Pentanet Limited has reported a solid half-year performance for the period ending 31 December 2025, with revenue growth and a significant surge in EBITDA, while narrowing its net loss. Both its Telecommunications and Gaming segments contributed to the improved results, supported by subscriber growth and operational efficiencies.

ZMM has reported a remarkable 253% increase in revenue for the half-year ending December 2025, yet still recorded a net loss of $1.078 million amid concerns over its financial sustainability.

Sprintex Limited reported a 162% surge in revenue to A$2.7 million for the half-year ending December 2025, driven by a landmark €15.6 million European contract. Despite this, the company posted a net loss of A$1.7 million, an improvement from the prior year, while raising $3.6 million to support global expansion.

NeuroScientific Biopharmaceuticals reported a $1.7 million loss for the half-year ending December 2025, driven by ongoing R&D investments. The company progressed clinical treatments for Crohn’s disease and glaucoma, alongside key leadership appointments and strategic partnerships.

Energy World Corporation has eliminated all group-level borrowings, strengthening its balance sheet and advancing key LNG and power projects in Southeast Asia amid ongoing operational losses.